Verapamil for Neuroprotection in Ischemic Stroke
Verapamil for Neuroprotection in Stroke
Recruiting
Phase 1
Phase 2
Interventional Study
Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Global Neurosciences Institute · Other
Who this trial is looking for
This trial is looking for patients with acute ischemic stroke who have had a specific procedure called mechanical thrombectomy. Participants will receive an experimental treatment involving a drug called verapamil and will be monitored for safety and recovery.
Are You a Good Fit for This Trial?
You may be able to join if
- I am at least 18 years old
- I have had a stroke within the last 8 hours
- I have a measurable neurological deficit
- I am a candidate for mechanical thrombectomy
- I am willing to follow up with rehabilitation therapy
- I expect to live at least 3 more months
- I have provided written consent
You may not be able to join if
- I am pregnant or might be pregnant
- I have severe liver or kidney problems
- I have a low platelet count
- I cannot tolerate verapamil
- I have had previous serious disability from a stroke
- I have had a severe stroke
- I am in a stupor or coma
- I am unlikely to be available for a 90-day follow-up
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery from stroke. Recruitment is limited to patients that have received mecha…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Written informed consent
* 18 years of age and over
* Acute onset focal neurologic deficit consistent with acute ischemic stroke, or computed tomographic scan consistent with acute cerebral ischemia
* Candidate for mechanical thrombectomy procedure
* Onset of symptoms less tha…
Contacts
No contact information available.